title: Complications of Bacillus Calmette-Guerin immunotherapy: review of 2602 patients and comparison of chemotherapy complications.
authors.forename: D L
authors.initials: DL
authors.lastname: Lamm
authors.forename: A
authors.initials: A
authors.lastname: Steg
authors.forename: L
authors.initials: L
authors.lastname: Boccon-Gibod
authors.forename: A
authors.initials: A
authors.lastname: Morales
authors.forename: M G
authors.initials: MG
authors.lastname: Hanna
authors.forename: F
authors.initials: F
authors.lastname: Pagano
authors.forename: O
authors.initials: O
authors.lastname: Alfthan
authors.forename: S
authors.initials: S
authors.lastname: Brosman
authors.forename: H A
authors.initials: HA
authors.lastname: Fisher
authors.forename: G
authors.initials: G
authors.lastname: Jakse
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D001500:BCG Vaccine / Q000009:adverse effects* / Q000145:classification; D004317:Doxorubicin / Q000009:adverse effects; D006801:Humans; D016685:Mitomycin; D008937:Mitomycins / Q000009:adverse effects; D018805:Sepsis / Q000209:etiology; D014376:Tuberculosis / Q000188:drug therapy / Q000209:etiology; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents; D001500:BCG Vaccine; D008937:Mitomycins; D016685:Mitomycin; D004317:Doxorubicin